Indeed, the restoration of p53 activity has been achieved by targeting MDMX with the stapled peptide SAH-p53-8, which blocks the formation of the p53–MDMX complex and restores the transcriptional upregulation of p53-related genes and the reduction of tumor cell viability [106]. This evidence concerns the gene MDM4 and neoplasm.